Form 4 for AGL agilon health, inc.
Accepted 2024-04-17 00:00:00 ET · period of report 2024-04-14 · accession 0001628280-24-016652 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-17 | 2024-04-15 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +252.2K | 336.3K | +300% | $0 |
| D | 2024-04-17 | 2024-04-14 | AGL | Sell Steven | CEO, Pres, Dir | F - Tax | $4.95 | -7,875 | 328.4K | -2% | -$39.0K |
| D | 2024-04-17 | 2024-04-15 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +415.1K | 415.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-15 | A | A | 252,243 | $0.00 | 336,322 | D | — | — | (F1) Restricted stock units that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment. (F2) Includes restricted stock units. |
| 2 | Common | Common Stock | 2024-04-14 | F | D | 7,875 | $4.95 | 328,447 | D | — | — | (F3) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. (F2) Includes restricted stock units. |
| 3 | Derivative | Options (Right to buy) | 2024-04-15 | A | A | 415,130 | $0.00 | 415,130 | D | $4.46 · — to 2034-04-15 | 415,130 Common Stock | (F5) Options that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment. |